Blog
RSS FeedPosted by Michael Wonder on 08 Oct 2020
Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study
7 October 2020 - The investigators of the study set out to characterise the therapeutic value of new drugs approved ...
Posted by Michael Wonder on 03 May 2018
How the U.S. compares to Europe on biosimilar approvals and products in the pipeline
2 May 2018 - FDA has not approved any biosimilar drug in 2018. ...
Posted by Michael Wonder on 28 Nov 2017
Comparing safety information of biosimilars with their originators: a cross-sectional analysis of European Risk Management Plans
22 November 2017 - Biosimilars have been available in the European Union since 2006. However, their uptake in routine care is ...